The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...
Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable ...
The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...
Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.
The Senate Committee on Health, Education, Labor and Pensions (HELP) is holding a hearing Wednesday morning focused on ...
Sen. Lindsey Graham (R-S.C.) will give remarks Wednesday afternoon about his opposition to abortion pills, which have been ...
Health and Human Services Secretary Robert F. Kennedy Jr. tells USA TODAY where his personal concerns about vaccines and food ...
For the first time in over 40 years, the Food and Drug Administration has approved a new treatment for motion sickness.
4don MSN
Legal questions swirl around FDA's new expedited drug program, including who should sign off
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for ...
More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...
Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback